Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Aceragen - 27 Year Stock Price History | ACGN

Historical daily share price chart and data for Aceragen since 1996 adjusted for splits and dividends. The latest closing stock price for Aceragen as of September 01, 2023 is 0.38.
  • The all-time high Aceragen stock closing price was 74119.90 on January 31, 1996.
  • The Aceragen 52-week high stock price is 0.00, which is -100% above the current share price.
  • The Aceragen 52-week low stock price is 0.00, which is 100% below the current share price.
  • The average Aceragen stock price for the last 52 weeks is 0.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Aceragen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 2.8349 7.8353 12.0683 0.3800 0.3800 -93.61%
2022 7.7625 10.0521 12.5256 3.9287 5.9500 -38.53%
2021 31.1503 68.2720 101.5580 8.9352 9.6798 -84.47%
2020 37.8303 31.3344 87.9716 18.0013 62.3271 101.64%
2019 44.1404 59.7805 67.4220 24.6262 30.9094 -34.29%
2018 190.8405 300.2590 346.4530 47.0424 47.0424 -83.59%
2017 262.4669 203.7960 376.3440 183.4160 286.6730 40.67%
2016 247.4777 407.5920 407.5920 179.3420 203.7960 -51.51%
2015 488.7182 666.4000 730.3230 330.4770 420.2420 -29.93%
2014 462.4139 646.0070 896.2420 266.5650 599.7580 -4.75%
2013 181.0293 108.1200 629.6770 62.5651 629.6770 420.21%
2012 150.4900 157.7650 282.8830 92.4834 121.0420 -15.24%
2011 279.8256 393.0420 442.0070 131.9230 142.8070 -63.67%
2010 552.4551 716.7230 943.8350 320.9650 393.0420 -44.10%
2009 871.2753 1092.0800 1232.1700 632.4070 703.1230 -32.68%
2008 1630.0189 1806.0800 2095.7600 803.7580 1044.4800 -41.37%
2007 1205.9855 718.0830 1781.6000 718.0830 1781.6000 143.04%
2006 575.4475 652.8000 780.6350 320.9650 733.0420 10.45%
2005 659.0941 544.0000 881.2700 500.5240 663.6700 27.08%
2004 791.6060 1229.4100 1425.2700 446.0700 522.2620 -57.89%
2003 1039.3352 783.3380 1838.7300 761.6000 1240.2800 62.85%
2002 1256.7289 1795.2500 1925.7900 652.8000 761.6000 -51.73%
2001 1049.5183 544.0000 2121.6500 533.1300 1577.6500 245.27%
2000 1651.7527 1088.0000 7072.0000 456.9380 456.9380 -58.42%
1999 998.3927 1360.0500 2040.0300 272.0540 1098.8700 -37.85%
1998 2343.5441 3536.0500 3672.0300 1223.9700 1767.9700 -45.83%
1997 23189.4111 32640.0000 40800.0000 2855.9700 3264.0000 -89.79%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.005B
Aceragen Inc. is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Its portfolio includes late-stage programs based on well-established biological principles. Aceragen Inc., formerly known as Idera Pharmaceuticals Inc., is based in DURHAM, N.C.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $262.317B 18.51
Amgen (AMGN) United States $172.422B 14.64
Gilead Sciences (GILD) United States $147.457B 14.51
Vertex Pharmaceuticals (VRTX) United States $103.890B 26.75
Bristol Myers Squibb (BMY) United States $95.049B 7.12
GSK (GSK) United Kingdom $94.678B 10.53
Regeneron Pharmaceuticals (REGN) United States $69.106B 17.93
Alnylam Pharmaceuticals (ALNY) United States $58.487B 1924.78
CSL (CSLLY) Australia $56.375B 0.00
Argenex SE (ARGX) Netherlands $52.620B 65.34
Insmed (INSM) United States $40.458B 0.00
Novozymes (NVZMY) Denmark $30.060B 0.00
BioNTech SE (BNTX) Germany $24.801B 0.00
Biogen (BIIB) United States $22.814B 9.29
Royalty Pharma (RPRX) United States $22.487B 8.53
Incyte (INCY) United States $20.806B 19.92
Genmab (GNMSF) Denmark $19.195B 14.08
Illumina (ILMN) United States $18.626B 27.96
Genmab (GMAB) Denmark $18.402B 13.85
Roivant Sciences (ROIV) United Kingdom $14.081B 0.00
Exact Sciences (EXAS) United States $12.539B 348.32
Swedish Orphan Biovitrum (BIOVF) Sweden $12.417B 23.10
Ascendis Pharma (ASND) Denmark $12.200B 0.00
Guardant Health (GH) United States $12.191B 0.00
Revolution Medicines (RVMD) United States $11.794B 0.00
Exelixis (EXEL) United States $10.942B 17.51
Avidity Biosciences (RNA) United States $10.190B 0.00
BioMarin Pharmaceutical (BMRN) United States $9.886B 17.93
QIAGEN (QGEN) Netherlands $9.683B 18.38
Moderna (MRNA) United States $9.587B 0.00
Bio-Techne Corp (TECH) United States $8.945B 33.38
Metsera (MTSR) United States $8.758B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.238B 29.62
Abivax SA (ABVX) France $8.193B 0.00
Repligen (RGEN) United States $8.039B 86.04
Halozyme Therapeutics (HALO) United States $8.025B 12.83
Jazz Pharmaceuticals (JAZZ) Ireland $7.970B 31.08
Cytokinetics (CYTK) United States $7.355B 0.00
Merus (MRUS) Netherlands $7.223B 0.00
Axsome Therapeutics (AXSM) United States $6.965B 0.00
Nuvalent (NUVL) United States $6.787B 0.00
Rhythm Pharmaceuticals (RYTM) United States $6.694B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.438B 0.00
Legend Biotech (LEGN) United States $5.869B 0.00
PTC Therapeutics (PTCT) United States $5.763B 7.83
Krystal Biotech (KRYS) United States $5.739B 29.67
Vaxcyte (PCVX) United States $5.452B 0.00
Alkermes (ALKS) Ireland $5.431B 15.97
Arrowhead Pharmaceuticals (ARWR) United States $5.424B 0.00
TG Therapeutics (TGTX) United States $5.118B 11.60
CRISPR Therapeutics AG (CRSP) Switzerland $5.013B 0.00
Arcellx (ACLX) United States $5.005B 0.00
Protagonist Therapeutics (PTGX) United States $4.973B 128.29
Zealand Pharma (ZLDPF) Denmark $4.769B 4.72
Akero Therapeutics (AKRO) United States $4.323B 0.00
Kymera Therapeutics (KYMR) United States $4.221B 0.00
Praxis Precision Medicines (PRAX) United States $4.207B 0.00
Viking Therapeutics (VKTX) United States $4.156B 0.00
Immunovant (IMVT) United States $4.070B 0.00
Ligand Pharmaceuticals (LGND) United States $3.968B 97.82
ACADIA Pharmaceuticals (ACAD) United States $3.818B 32.24
Belite Bio (BLTE) United States $3.604B 0.00
Mirum Pharmaceuticals (MIRM) United States $3.500B 0.00
ADMA Biologics Inc (ADMA) United States $3.465B 24.61
Telix Pharmaceuticals (TLX) Australia $3.287B 0.00
Celcuity (CELC) United States $3.162B 0.00
CG Oncology (CGON) United States $3.026B 0.00
Arcutis Biotherapeutics (ARQT) United States $2.968B 0.00
Ascentage Pharma Group - (AAPG) China $2.961B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.956B 0.00
Jyong Biotech (MENS) Taiwan $2.955B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.955B 0.00
Disc Medicine (IRON) United States $2.915B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.908B 85.27
Tarsus Pharmaceuticals (TARS) United States $2.897B 0.00
Travere Therapeutics (TVTX) United States $2.894B 0.00
GRAIL (GRAL) United States $2.862B 0.00
Scholar Rock Holding (SRRK) United States $2.783B 0.00
Amicus Therapeutics (FOLD) United States $2.737B 221.75
IDEAYA Biosciences (IDYA) United States $2.651B 0.00
Cidara Therapeutics (CDTX) United States $2.647B 0.00
Viridian Therapeutics (VRDN) United States $2.619B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.608B 0.00
Apogee Therapeutics (APGE) United States $2.523B 0.00
Mineralys Therapeutics (MLYS) United States $2.521B 0.00
Anbio Biotechnology (NNNN) Germany $2.461B 0.00
Zai Lab (ZLAB) China $2.448B 0.00
Apellis Pharmaceuticals (APLS) United States $2.437B 62.13
Agios Pharmaceuticals (AGIO) United States $2.372B 0.00
Bavarian Nordic (BVNRY) Denmark $2.308B 11.16
Liquidia (LQDA) United States $2.270B 0.00
Adaptive Biotechnologies (ADPT) United States $2.258B 0.00
Beam Therapeutics (BEAM) United States $2.254B 0.00
Denali Therapeutics (DNLI) United States $2.203B 0.00
ImmunityBio (IBRX) United States $2.098B 0.00
Arcus Biosciences (RCUS) United States $2.085B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.006B 0.00
Vericel (VCEL) United States $1.969B 162.25
ANI Pharmaceuticals (ANIP) United States $1.962B 15.75
Structure Therapeutics (GPCR) United States $1.892B 0.00
Mesoblast (MESO) Australia $1.874B 0.00
Twist Bioscience (TWST) United States $1.827B 0.00
Edgewise Therapeutics (EWTX) United States $1.817B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.810B 9.88
MannKind (MNKD) United States $1.729B 56.30
Sarepta Therapeutics (SRPT) United States $1.723B 0.00
Alvotech (ALVO) Luxembourg $1.721B 12.98
Immunocore Holdings (IMCR) United Kingdom $1.688B 0.00
Cogent Biosciences (COGT) United States $1.687B 0.00
Nuvation Bio (NUVB) United States $1.622B 0.00
Terns Pharmaceuticals (TERN) United States $1.616B 0.00
Janux Therapeutics (JANX) United States $1.591B 0.00
Sionna Therapeutics (SION) United States $1.549B 0.00
Vera Therapeutics (VERA) United States $1.544B 0.00
UniQure (QURE) Netherlands $1.525B 0.00
Celldex Therapeutics (CLDX) United States $1.521B 0.00
Zenas BioPharma (ZBIO) United States $1.415B 0.00
Certara (CERT) United States $1.393B 25.50
Maze Therapeutics (MAZE) United States $1.375B 0.00
Spyre Therapeutics (SYRE) United States $1.360B 0.00
Trevi Therapeutics (TRVI) United States $1.341B 0.00
Immunome (IMNM) United States $1.327B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.307B 0.00
Stoke Therapeutics (STOK) United States $1.306B 34.12
NeoGenomics (NEO) United States $1.304B 0.00
Dynavax Technologies (DVAX) United States $1.272B 37.35
WAVE Life Sciences (WVE) Singapore $1.251B 0.00
Upstream Bio (UPB) United States $1.241B 0.00
Zymeworks (ZYME) United States $1.237B 0.00
NovoCure (NVCR) Jersey $1.223B 0.00
Novavax (NVAX) United States $1.209B 3.07
Oric Pharmaceuticals (ORIC) United States $1.199B 0.00
Inhibrx Biosciences (INBX) United States $1.169B 0.00
CureVac (CVAC) Germany $1.169B 5.43
AbCellera Biologics (ABCL) Canada $1.168B 0.00
Dianthus Therapeutics (DNTH) United States $1.168B 0.00
Precigen (PGEN) United States $1.162B 0.00
Pharvaris (PHVS) Netherlands $1.129B 0.00
MiMedx (MDXG) United States $1.102B 19.58
Immatics (IMTX) Germany $1.100B 0.00
AnaptysBio (ANAB) United States $1.098B 0.00
Urogen Pharma (URGN) United States $1.088B 0.00
Tango Therapeutics (TNGX) United States $1.059B 0.00
Pharming Group (PHAR) Netherlands $1.057B 0.00
Fortrea Holdings (FTRE) United States $1.040B 22.06
Pharming Group (PHGUF) Netherlands $1.027B 153.00
Intellia Therapeutics (NTLA) United States $1.022B 0.00
Oculis Holding AG (OCS) Switzerland $1.007B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.999B 0.00
Pacira BioSciences (PCRX) United States $0.991B 10.86
Rezolute (RZLT) United States $0.977B 0.00
Sana Biotechnology (SANA) United States $0.973B 0.00
Castle Biosciences (CSTL) United States $0.964B 132.16
BridgeBio Oncology Therapeutics (BBOT) United States $0.962B 0.00
Nanobiotix S.A - (NBTX) France $0.953B 0.00
Nurix Therapeutics (NRIX) United States $0.946B 0.00
BGM Group (BGM) China $0.943B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.943B 0.00
Rapport Therapeutics (RAPP) United States $0.937B 0.00
Kodiak Sciences (KOD) United States $0.931B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.928B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.922B 0.00
Iovance Biotherapeutics (IOVA) United States $0.913B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.890B 0.00
Biohaven (BHVN) United States $0.874B 0.00
Arbutus Biopharma (ABUS) United States $0.863B 0.00
Palvella Therapeutics (PVLA) United States $0.861B 0.00
MBX Biosciences (MBX) United States $0.859B 0.00
Kura Oncology (KURA) United States $0.858B 0.00
CorMedix Inc (CRMD) United States $0.843B 14.35
Septerna (SEPN) United States $0.825B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.802B 38.47
Bicara Therapeutics (BCAX) United States $0.800B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.790B 0.00
Tyra Biosciences (TYRA) United States $0.764B 0.00
ArriVent BioPharma (AVBP) United States $0.732B 0.00
LENZ Therapeutics (LENZ) United States $0.719B 0.00
Vir Biotechnology (VIR) United States $0.714B 0.00
Astria Therapeutics (ATXS) United States $0.706B 0.00
GH Research (GHRS) Ireland $0.702B 0.00
Gyre Therapeutics (GYRE) United States $0.694B 90.12
MoonLake Immunotherapeutics (MLTX) Switzerland $0.683B 0.00
Arvinas (ARVN) United States $0.683B 0.00
Geron (GERN) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.681B 0.00
Replimune (REPL) United States $0.652B 0.00
MapLight Therapeutics (MPLT) $0.647B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Erasca (ERAS) United States $0.644B 0.00
Anavex Life Sciences (AVXL) United States $0.626B 0.00
Ventyx Biosciences (VTYX) United States $0.625B 0.00
CytomX Therapeutics (CTMX) United States $0.613B 9.05
Cytek Biosciences (CTKB) United States $0.591B 0.00
Myriad Genetics (MYGN) United States $0.587B 0.00
Compass Therapeutics (CMPX) United States $0.585B 0.00
Opthea (OPT) Australia $0.583B 0.00
Olema Pharmaceuticals (OLMA) United States $0.573B 0.00
Prothena (PRTA) Ireland $0.568B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.568B 0.00
REGENXBIO (RGNX) United States $0.567B 0.00
Inventiva S.A (IVA) France $0.558B 0.00
Gossamer Bio (GOSS) United States $0.546B 0.00
Niagen Bioscience (NAGE) United States $0.546B 42.75
Verastem (VSTM) United States $0.539B 0.00
Emergent Biosolutions (EBS) United States $0.534B 5.13
Ginkgo Bioworks Holdings (DNA) United States $0.530B 0.00
Prime Medicine (PRME) United States $0.513B 0.00
Monopar Therapeutics (MNPR) United States $0.499B 0.00
Absci (ABSI) United States $0.499B 0.00
Keros Therapeutics (KROS) United States $0.494B 10.52
Alumis (ALMS) United States $0.491B 0.00
Rapt Therapeutics (RAPT) United States $0.477B 0.00
DBV Technologies S.A (DBVT) France $0.473B 0.00
NovaBridge Biosciences (NBP) United States $0.461B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.455B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.454B 0.00
Eton Pharmaceuticals (ETON) United States $0.453B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.446B 0.00
Design Therapeutics (DSGN) United States $0.431B 0.00
Cullinan Therapeutics (CGEM) United States $0.425B 0.00
Ocugen (OCGN) United States $0.425B 0.00
PureTech Health (PRTC) United States $0.423B 0.00
Neumora Therapeutics (NMRA) United States $0.415B 0.00
Bright Minds Biosciences (DRUG) United States $0.414B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
XOMA Royalty (XOMA) United States $0.401B 0.00
LB Pharmaceuticals Inc (LBRX) United States $0.388B 0.00
Kamada (KMDA) Israel $0.383B 19.59
Neurogene (NGNE) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.375B 0.00
Invivyd (IVVD) United States $0.370B 0.00
Tectonic Therapeutic (TECX) United States $0.362B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.354B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.343B 0.00
Benitec Biopharma (BNTC) United States $0.336B 0.00
Aura Biosciences (AURA) United States $0.332B 0.00
AC Immune (ACIU) Switzerland $0.331B 0.00
Amarin (AMRN) Ireland $0.325B 0.00
Contineum Therapeutics (CTNM) United States $0.319B 0.00
Annexon (ANNX) United States $0.316B 0.00
Solid Biosciences (SLDB) United States $0.316B 0.00
Alto Neuroscience (ANRO) United States $0.313B 0.00
EnGene Holdings (ENGN) Canada $0.310B 0.00
DiaMedica Therapeutics (DMAC) United States $0.306B 0.00
Puma Biotechnology (PBYI) United States $0.302B 8.09
Jade Biosciences (JBIO) United States $0.300B 0.00
Immuneering (IMRX) United States $0.286B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.286B 0.00
Kyverna Therapeutics (KYTX) United States $0.285B 0.00
Candel Therapeutics (CADL) United States $0.277B 0.00
Allogene Therapeutics (ALLO) United States $0.265B 0.00
Entrada Therapeutics (TRDA) United States $0.264B 0.00
BioAge Labs (BIOA) United States $0.260B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.260B 0.00
Atea Pharmaceuticals (AVIR) United States $0.260B 0.00
Lifecore Biomedical (LFCR) United States $0.257B 0.00
Alpha Teknova (TKNO) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.249B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Sagimet Biosciences (SGMT) United States $0.245B 0.00
Zura Bio (ZURA) United States $0.239B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.237B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Voyager Therapeutics (VYGR) United States $0.235B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.234B 0.00
Cabaletta Bio (CABA) United States $0.233B 0.00
Adherex Technologies (FENC) United States $0.224B 0.00
Palisade Bio (PALI) United States $0.223B 0.00
Editas Medicine (EDIT) United States $0.222B 0.00
Black Diamond Therapeutics (BDTX) United States $0.222B 10.81
Aardvark Therapeutics (AARD) United States $0.220B 0.00
Adocia (ADOCY) France $0.216B 0.00
Abeona Therapeutics (ABEO) United States $0.215B 4.57
Orchestra BioMed Holdings (OBIO) United States $0.215B 0.00
Humacyte (HUMA) United States $0.211B 0.00
Tenaya Therapeutics (TNYA) United States $0.209B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.208B 0.00
Genelux (GNLX) United States $0.206B 0.00
Cartesian Therapeutics (RNAC) United States $0.205B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.204B 0.00
SELLAS Life Sciences (SLS) United States $0.199B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.196B 0.00
Caribou Biosciences (CRBU) United States $0.195B 0.00
GENFIT S.A (GNFT) France $0.195B 0.00
Molecular Partners AG (MOLN) Switzerland $0.191B 0.00
Nautilus Biotechnology (NAUT) United States $0.191B 0.00
Crescent Biopharma (CBIO) United States $0.182B 0.00
C4 Therapeutics (CCCC) United States $0.167B 0.00
Innate Pharma S.A (IPHA) France $0.164B 0.00
Coherus Oncology (CHRS) United States $0.162B 0.00
Sangamo Therapeutics (SGMO) United States $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.157B 0.00
MaxCyte (MXCT) United States $0.154B 0.00
Codexis (CDXS) United States $0.153B 0.00
PepGen (PEPG) United States $0.152B 0.00
Forte Biosciences (FBRX) United States $0.150B 0.00
Cognition Therapeutics (CGTX) United States $0.147B 0.00
Cardiff Oncology (CRDF) United States $0.146B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.145B 0.00
Rani Therapeutics Holdings (RANI) United States $0.145B 0.00
Elicio Therapeutics (ELTX) United States $0.145B 0.00
Compugen (CGEN) Israel $0.145B 0.00
Entera Bio (ENTX) Israel $0.143B 0.00
Actuate Therapeutics (ACTU) United States $0.143B 0.00
Scilex Holding (SCLX) United States $0.143B 0.00
Anika Therapeutics (ANIK) United States $0.142B 0.00
Alector (ALEC) United States $0.140B 0.00
Nkarta (NKTX) United States $0.139B 0.00
Spero Therapeutics (SPRO) United States $0.138B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.138B 0.00
Opus Genetics (IRD) United States $0.130B 0.00
TuHURA Biosciences (HURA) United States $0.129B 0.00
Vor Biopharma (VOR) $0.128B 0.00
Seres Therapeutics (MCRB) United States $0.127B 0.00
Agenus (AGEN) United States $0.127B 0.00
Climb Bio (CLYM) United States $0.125B 0.00
Fate Therapeutics (FATE) United States $0.123B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.123B 0.00
VistaGen Therapeutics (VTGN) United States $0.122B 0.00
Applied Therapeutics (APLT) United States $0.122B 0.00
Greenwich LifeSciences (GLSI) United States $0.120B 0.00
Alpha Cognition (ACOG) Canada $0.120B 0.00
Seer (SEER) United States $0.118B 0.00
EXoZymes (EXOZ) United States $0.117B 0.00
BioHarvest Sciences (BHST) Canada $0.117B 0.00
Citius Oncology (CTOR) United States $0.117B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
Turn Therapeutics (TTRX) United States $0.113B 0.00
Estrella Immunopharma (ESLA) United States $0.109B 0.00
Immix Biopharma (IMMX) United States $0.104B 0.00
VTv Therapeutics (VTVT) United States $0.102B 0.00
Oncolytics Biotech (ONCY) Canada $0.102B 0.00
Instil Bio (TIL) United States $0.102B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.099B 0.00
Clene (CLNN) United States $0.099B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Tevogen Bio Holdings (TVGN) United States $0.098B 0.00
Whitehawk Therapeutics (WHWK) United States $0.098B 0.00
Biomea Fusion (BMEA) United States $0.097B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.097B 0.00
Coya Therapeutics (COYA) United States $0.096B 0.00
Starpharma Holdings (SPHRY) Australia $0.096B 0.00
Shattuck Labs (STTK) United States $0.095B 0.00
Ovid Therapeutics (OVID) United States $0.094B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.092B 0.00
OKYO Pharma (OKYO) $0.092B 0.00
Adverum Biotechnologies (ADVM) United States $0.091B 0.00
23andMe Holding (MEHCQ) United States $0.090B 0.00
Kalaris Therapeutics (KLRS) United States $0.089B 0.00
Connect Biopharma Holdings (CNTB) United States $0.086B 0.00
CAMP4 Therapeutics (CAMP) United States $0.086B 0.00
Artiva Biotherapeutics (ARTV) United States $0.085B 0.00
Quince Therapeutics (QNCX) United States $0.084B 0.00
Atara Biotherapeutics (ATRA) United States $0.083B 0.00
InflaRx (IFRX) Germany $0.083B 0.00
Precision BioSciences (DTIL) United States $0.081B 0.00
ATyr Pharma (ATYR) United States $0.080B 0.00
BeyondSpring (BYSI) United States $0.079B 0.00
Fortress Biotech (FBIO) United States $0.078B 0.00
ALX Oncology Holdings (ALXO) United States $0.074B 0.00
Repare Therapeutics (RPTX) Canada $0.073B 0.00
XBiotech (XBIT) United States $0.071B 0.00
Immunic (IMUX) United States $0.071B 0.00
ABVC BioPharma (ABVC) United States $0.071B 0.00
Sutro Biopharma (STRO) United States $0.070B 0.00
Adagene (ADAG) China $0.066B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.066B 0.00
Equillium (EQ) United States $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Spruce Biosciences (SPRB) United States $0.064B 0.00
BioStem Technologies (BSEM) $0.062B 3.26
TScan Therapeutics (TCRX) United States $0.062B 0.00
MiNK Therapeutics (INKT) United States $0.060B 0.00
Adlai Nortye (ANL) Cayman Islands $0.057B 0.00
Werewolf Therapeutics (HOWL) United States $0.056B 0.00
Cue Biopharma (CUE) United States $0.054B 0.00
Adicet Bio (ACET) United States $0.053B 0.00
Oncobiologics (OTLK) United States $0.053B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Celularity (CELU) United States $0.048B 0.00
Skye Bioscience (SKYE) United States $0.047B 0.00
TELA Bio (TELA) United States $0.046B 0.00
Radiopharm Theranostics - (RADX) Australia $0.046B 0.00
Hyperion DeFi (HYPD) United States $0.045B 0.00
Kezar Life Sciences (KZR) United States $0.044B 0.00
Genenta Science S.p.A (GNTA) Italy $0.044B 0.00
CalciMedica (CALC) United States $0.044B 0.00
Barinthus Biotherapeutics (BRNS) United States $0.044B 0.00
Aligos Therapeutics (ALGS) United States $0.043B 0.00
INmune Bio (INMB) United States $0.043B 0.00
PDS Biotechnology (PDSB) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.043B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.042B 0.00
X4 Pharmaceuticals (XFOR) United States $0.042B 0.00
Mersana Therapeutics (MRSN) United States $0.042B 0.00
Xilio Therapeutics (XLO) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.041B 0.00
BioAtla (BCAB) United States $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.040B 0.00
Elutia (ELUT) United States $0.038B 0.00
Tvardi Therapeutics (TVRD) United States $0.038B 0.00
Rein Therapeutics (RNTX) United States $0.037B 0.00
Lantern Pharma (LTRN) United States $0.037B 0.00
RenovoRx (RNXT) United States $0.035B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.034B 0.00
Generation Bio (GBIO) United States $0.034B 0.00
Quantum Biopharma (QNTM) Canada $0.034B 0.00
Femasys (FEMY) United States $0.034B 0.00
Dyadic (DYAI) United States $0.034B 0.00
SAB Biotherapeutics (SABS) United States $0.033B 0.00
ImageneBio (IMA) United States $0.033B 0.00
Tenax Therapeutics (TENX) United States $0.032B 0.00
Tharimmune (THAR) United States $0.032B 0.00
AN2 Therapeutics (ANTX) United States $0.031B 0.00
Alterity Therapeutics - (ATHE) Australia $0.031B 0.00
BioXcel Therapeutics (BTAI) United States $0.029B 0.00
Synaptogenix (TAOX) United States $0.029B 0.00
Jasper Therapeutics (JSPR) United States $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.028B 0.00
Q32 Bio (QTTB) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
Pluri (PLUR) Israel $0.027B 0.00
IBio (IBIO) United States $0.027B 0.00
Rallybio (RLYB) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.025B 0.00
Intensity Therapeutics (INTS) United States $0.025B 0.00
Exicure (XCUR) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Dare Bioscience (DARE) United States $0.025B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.024B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
NextCure (NXTC) United States $0.024B 0.00
Lexaria Bioscience (LEXX) Canada $0.023B 0.00
MetaVia (MTVA) United States $0.022B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Promis Neurosciences (PMN) Canada $0.020B 0.00
Cingulate (CING) United States $0.020B 0.00
Passage Bio (PASG) United States $0.020B 0.00
Clearside Biomedical (CLSD) United States $0.019B 0.00
Leap Therapeutics (LPTX) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
NewcelX (NCEL) Switzerland $0.018B 0.00
FibroBiologics (FBLG) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.018B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Curis (CRIS) United States $0.016B 0.00
Hoth Therapeutics (HOTH) United States $0.016B 0.00
Apollomics (APLM) United States $0.016B 0.00
Longeveron (LGVN) United States $0.016B 0.00
GeoVax Labs (GOVX) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.015B 0.00
Revelation Biosciences (REVB) United States $0.015B 0.00
Abpro Holdings (ABP) United States $0.015B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
BioCardia (BCDA) United States $0.014B 0.00
Chemomab Therapeutics (CMMB) Israel $0.014B 0.00
Propanc Biopharma Inc (PPCB) Australia $0.013B 0.00
Novogen (KZIA) Australia $0.012B 0.00
Dogwood Therapeutics (DWTX) United States $0.012B 0.00
Edesa Biotech (EDSA) Canada $0.012B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Cocrystal Pharma (COCP) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
Purple Biotech (PPBT) Israel $0.011B 0.00
Imunon (IMNN) United States $0.010B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.010B 0.00
Gelteq (GELS) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.009B 0.00
Advanced Biomed (ADVB) United States $0.009B 0.00
Bolt Biotherapeutics (BOLT) United States $0.009B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.009B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Avalon GloboCare (ALBT) United States $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
BRIACELL THERAP (BCTX) Canada $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Aprea Therapeutics (APRE) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Bionano Genomics (BNGO) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
HCW Biologics (HCWB) United States $0.007B 0.00
Entero Therapeutics (ENTO) United States $0.006B 0.00
Evogene (EVGN) Israel $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Arcadia Biosciences (RKDA) United States $0.005B 0.00
KALA BIO (KALA) United States $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Black Titan (BTTC) United States $0.004B 0.00
Psyence Biomedical (PBM) Canada $0.004B 0.00
Onconetix (ONCO) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Alps Group (ALPS) United States $0.003B 2.21
GT Biopharma (GTBP) United States $0.002B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Artelo Biosciences (ARTL) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Cellectis S.A (CLLS) France $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
IO Biotech (IOBT) Denmark $0.000B 0.00
MediciNova (MNOV) United States $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
YD Bio (YDES) $0.000B 0.00